Exchange: NASDAQ·Updated 04:00 AM EDT
AKTX logo

AKTX Akari Therapeutics

$9.38
$0.22
(2.40%)
Pre-Market
Prev Close $9.16
Mkt Cap$16.03M
Vol5.00

About AKTX

Akari Therapeutics Plc is a clinical-stage biopharmaceutical company. It engages in the development and commercialization of therapeutics to treat orphan autoimmune and inflammatory diseases. The company was founded on October 7, 2004 and is headquartered in Tampa, FL.
36

Bearish Sentiment

How do you feel about AKTX?

Advertisement|Remove ads.